The Journal focuses on COVID-19; Wuhan; 2019 novel Coronavirus; Point-of-care detection; SARS-CoV-2; (Loop-mediated isothermal amplification) LAMP assay; (polymerase chain reaction) PCR. We believe a point-of-care (PoC) device for the rapid detection of the 2019 novel Coronavirus (SARS-CoV-2) is crucial and urgently needed. With this perspective, we give suggestions regarding a potential candidate for the rapid detection of the coronavirus disease 2019 (COVID-19), as well as factors for the preparedness and response to the outbreak of the COVID-19. On 30 January 2020, the World Health Organization (WHO) declared a global public health emergency over the outbreak of the new coronavirus, called the 2019 novel Coronavirus (2019-nCoV), which originated in Wuhan City, in the Hubei Province of China. On 11 February, WHO officially named the disease as the coronavirus disease 2019 (COVID-19). Human-to-human transmission has been confirmed by WHO and by The Centers for Disease Control and Prevention (CDC) of the United States, with evidence of person-to-person transmission from three different cases outside China, namely in the US, Germany, and Vietnam. COVID-19 has continuously spread to 104 countries; the number of confirmed infections reached 109,343 on 9 March 2020, and the death toll in China has overtaken the SARS epidemic of 2002–2003 and has risen to 3,100. To slow down the spread of COVID-19, at least 50 million people in China have been placed under lockdown. On 8 March 2020, Italy also undertook the same measures, with the northern part of the country placed under lockdown, affecting 16 million people. The definition of coronaviruses is listed in. The reproduction number R₀ (i.e., the average number of secondary cases generated by a typical infectious individual) is estimated to be 2.68, and the doubling time is estimated to be 6.4 days.

 Submit manuscripts at https://www.scholarscentral.org/submissions/pharmaceutical-sciences-emerging-drugs.html or an e-mail attachment to the Editorial Office at manuscripts@scitechnol.com

Best Regards,
Editorial Manager
Journal of Pharmaceutical Sciences & Emerging Drugs
Email: editor.jpsed@peerjournal.org